Quality management in rectal carcinoma: What is feasible?

International Journal of Colorectal Disease

Volumn 24, Issue 8, 2009, Pages 931-942

  Merkel, Susanne ^a   Klossek, Daniela ^a   Göhl, Jonas ^a   Papadopoulos, Thomas ^b   Hohenberger, Werner ^a   Hermanek, Paul ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Vivantes Klinikum Spandau   (Germany)

Author keywords

Guidelines; Quality indicator; Quality management; Rectal carcinoma; Target value

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECTUM CARCINOMA; RECTUM SURGERY; RECURRENCE RISK; SURVIVAL RATE; SURVIVAL TIME; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEASIBILITY STUDIES; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; QUALITY INDICATORS, HEALTH CARE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; REGISTRIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649502864     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0736-9     Document Type: Article

References (39)

1. Soreide O, Norstein J, Fielding LP, Silen W (1997) International standardization and documentation of the treatment of rectal cancer. In: Soreide O, Norstein J (eds) Rectal Cancer Surgery. Optimisation-standardisation-documentation. Springer, Berlin, pp 405-445
2. Schmiegel W, Pox C, Adler G, Fleig W, Fölsch UR, Frühmorgen P, Graeven U, Hohenberger W, Holstege A, Junginger T, Kühlbacher T, Porschen R, Propping P, Riemann JF, Sauer R, Sauerbruch T, Schmoll HJ, Zeitz M, Selbmann HK (2004) S3-Leitlinienkonferenz "Kolorektales Karzinom" 2004. Z Gastroenterol 42:1129-1177
3. Schmiegel W, Reinacher-Schick A, Arnold D, Graeven U, Heinemann V, Porschen R, Riemann J, Rödel C, Sauer R, Wieser M, Schmitt W, Schmoll HJ, Seufferlein T, Kopp I, Pox C (2008) S3-Leitlinie "olorektales Karzinom" - Aktualisierung 2008. Z Gastroenterol 46:799-840
4. Bittner R, Burghardt J, Gross E, Grundmann RT, Hermanek P, Isbert C, Junginger T, Köckerling F, Merkel S, Möslein G, Raab HR, Roder J, Ruf G, Schwenk W, Strassburg J, Tannapfel A, de Vries A, Zühlke H (2007) Qualitätsindikatoren bei Diagnostik und Therapie des Rektumkarzinoms. Zentralblatt für Chirurgie 132:85-94
5. Sobin LH, Wittekind Ch (eds) UICC (2002): TNM classification of malignant tumours, 6th edn. Wiley, New York
6. UICC (2003) TNM Supplement. In: Wittekind Ch, Greene FL, Henson DE, Hutter RVP, Sobin LH (eds) A commentary on uniform use, 3rd edn. Wiley-Liss, New York
7. Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 69:613-616
8. Compton CC (2002) Pathologic prognostic factors in the recurrence of rectal cancer. Clin Colorectal Cancer 2:149-160
9. Hermanek P, Hermanek P, Hohenberger W, Klimpfinger M, Köckerling F, Papadopoulos T (2003) The pathological assessment of mesorectal excision: Implications for further treatment and quality management. Int J Colorectal Dis 18:335-341
10. Maughan NJ, Quirke P (2003) Modern management of colorectal cancer - a pathologist's view. Scand J Surg 92:11-19
11. Nagtegaal ID, van de Velde CJH, Marijnen CAM, van Krieken JHJM, Quirke P (2005) Low rectal cancer: A call for a change of approach in abdominoperineal resection. J Clin Oncol 23:9257-9264
12. Glynne-Jones R, Mawdsley S, Novell JR (2006) The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: Why we need a common language. Colorectal Dis 8:800-807
13. Junginger T, Kneist W, Sultanov F, Heintz A (2003) Qualitätsindikatoren der chirurgischen Therapie des Rektumkarzinoms. Chirurg 74:444-451
14. Steinert R, Marusch F, Koch A, Ptok H, Reymond MA, Gastinger I (2005) Möglichkeiten der Qualitätsverbesserung bei der Therapie des Rektumkarzinoms. Zentralbl Chir 130:387-392
15. Lippert H, Gastinger I (2006) Versorgung von Patienten mit Rektumkarzinomen in Deutschland. Deutsches Årzteblatt 103:A2704-A2709
16. Ptok H, Marusch F, Kuhn R, Gastinger I, Lippert H (2007) Influence of hospital volume on the frequency of abdominoperineal resection and long-term oncological outcomes in low rectal cancer. Eur J Surg Oncol 33:854-861
17. Benchmarking Darmzentren WDC. Bericht 1. Halbjahr 2007. Available via: http://www.brustcentrum.de/doc/controls/document/docrender.aspx?ID=96. Accessed 15 Jan 2009
18. Luna-Pérez P, Rodríguez-Ramírez S, Alvarado I, Gutiérrez de la Barrera M, Labastida S (2003) Prognostic significance of retrieved lymph nodes per specimen in resected rectal adenocarcinoma after preoperative chemoradiation therapy. Arch Med Res 34:281-286
19. Hermanek P (1994) Hermanek P, Marzoli GP. In: Hermanek P, Marzoli GP (eds) Lokale Therapie des Rektumkarzinoms in kurativer Intention. Springer, Berlin, pp 7-19
20. Sengupta S, Tjandra JJ (2001) Local excision of rectal cancer: What is the evidence? Dis Colon Rectum 44:1345-1361
21. Matzel KE, Merkel S, Hohenberger W (2003) Lokale Therapieprinzipien beim Rektumkarzinom. Chirurg 74:897-904
22. Borschitz T, Gockel I, Kiesslich R, Junginger T (2008) Oncological outcome after local excision of rectal carcinomas. Ann Surg Oncol 15:3101-3108
23. Bittorf B, Stadelmaier U, Göhl J, Hohenberger W, Matzel KE (2004) Functional outcome after intersphincteric resection of the rectum with coloanal anastomosis in low rectal cancer. Eur J Surg Oncol 30:260-265
24. Gervaz P, Bucher P, Konrad B, Morel P, Beyeler S, Lataillade L, Allal A (2008) A prospective longitudinal evaluation of quality of life after abdominoperineal resection. J Surg Oncol 97:14-19
25. Schmidt O, Merkel S, Hohenberger W (2003) Anastomotic leakage after low rectal stapler anastomosis: Significance of intraoperative anastomotic testing. Eur J Surg Oncol 29:239-243
26. Bittorf B, Stadelmaier U, Merkel S, Hohenberger W, Matzel KE (2003) Does anastomotic leakage affect functional outcome after rectal resection for cancer? Langenbecks Arch Surg 387:406-410
27. Merkel S, Wang WY, Schmidt O, Dworak O, Wittekind C, Hohenberger W, Hermanek P (2001) Locoregional recurrence in patients with anastomotic leakage after anterior resection for rectal carcinoma. Colorectal Dis 3:154-160
28. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer 29. Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740
29. Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P (2001) The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 16:298-304
30. Zirngibl H, Husemann B, Hermanek P (1990) Intraoperative spillage of tumor cells in surgery of rectal cancer. Dis Colon Rectum 33:610-614
31. Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH, Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group (2002) Macroscopic evaluation of rectal cancer resection specimen: Clinical significance of the pathologist in quality control. J Clin Oncol 20:1729-1734
32. Maslekar S, Sharma A, Macdonald A, Gunn J, Monson JR, Hartley JE (2007) Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum 50:168-175
33. Quirke P, Guillou P, Thorpe H et al (2006) Circumferential margins in rectum and right colon in the MRC CLASSIC trial: 3 year disease free survival and local recurrence. J Pathol 208:30A
34. Nagtegaal ID, Quirke P (2008) What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26:303-312
35. Strassburg J, Junginger T, Trinh T, Püttcher O, Oberholzer K, Heald RJ, Hermanek P (2008) Magnetic resonance imaging (MRI)-based indication for neoadjuvant treatment of rectal carcinoma and the surrogate endpoint CRM status. Int J Colorectal Dis 23:1099-1107
36. Merkel S, Meyer T, Göhl J, Hohenberger W (2002) Late locoregional recurrence in rectal carcinoma. Eur J Surg Oncol 28:716-722
37. EUROCARE Homepage. Available via: http://www.eurocare.it/. Accessed 31 Mar 2009
38. SEER Homepage. Available via: http://seer.cancer.gov/index.html. Accessed 31 Mar 2009
39. Deutsche Krebsgesellschaft e. V. (2009) Erhebungsbogen für Darmzentren der Deutschen Krebsgesellschaft. Available via: http://www.krebsgesellschaft.de/download/eb_darm-b1_12.03.2009.doc. Accessed 31 Mar 2009